409 related articles for article (PubMed ID: 18369166)
1. Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia.
Zhang W; Otsuka T; Sugo N; Ardeshiri A; Alhadid YK; Iliff JJ; DeBarber AE; Koop DR; Alkayed NJ
Stroke; 2008 Jul; 39(7):2073-8. PubMed ID: 18369166
[TBL] [Abstract][Full Text] [Related]
2. Role of soluble epoxide hydrolase in the sex-specific vascular response to cerebral ischemia.
Zhang W; Iliff JJ; Campbell CJ; Wang RK; Hurn PD; Alkayed NJ
J Cereb Blood Flow Metab; 2009 Aug; 29(8):1475-81. PubMed ID: 19471280
[TBL] [Abstract][Full Text] [Related]
3. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
Motoki A; Merkel MJ; Packwood WH; Cao Z; Liu L; Iliff J; Alkayed NJ; Van Winkle DM
Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2128-34. PubMed ID: 18835921
[TBL] [Abstract][Full Text] [Related]
4. Soluble epoxide hydrolase: a novel therapeutic target in stroke.
Zhang W; Koerner IP; Noppens R; Grafe M; Tsai HJ; Morisseau C; Luria A; Hammock BD; Falck JR; Alkayed NJ
J Cereb Blood Flow Metab; 2007 Dec; 27(12):1931-40. PubMed ID: 17440491
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling.
Merkel MJ; Liu L; Cao Z; Packwood W; Young J; Alkayed NJ; Van Winkle DM
Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H679-87. PubMed ID: 20008276
[TBL] [Abstract][Full Text] [Related]
6. EET-dependent potentiation of pulmonary arterial pressure: sex-different regulation of soluble epoxide hydrolase.
Kandhi S; Qin J; Froogh G; Jiang H; Luo M; Wolin MS; Huang A; Sun D
Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(12):L1478-86. PubMed ID: 26498250
[TBL] [Abstract][Full Text] [Related]
7. Soluble epoxide hydrolase gene deletion improves blood flow and reduces infarct size after cerebral ischemia in reproductively senescent female mice.
Zuloaga KL; Zhang W; Roese NE; Alkayed NJ
Front Pharmacol; 2014; 5():290. PubMed ID: 25642188
[TBL] [Abstract][Full Text] [Related]
8. Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism.
Marowsky A; Burgener J; Falck JR; Fritschy JM; Arand M
Neuroscience; 2009 Oct; 163(2):646-61. PubMed ID: 19540314
[TBL] [Abstract][Full Text] [Related]
9. Soluble epoxide hydrolase gene deletion reduces survival after cardiac arrest and cardiopulmonary resuscitation.
Hutchens MP; Nakano T; Dunlap J; Traystman RJ; Hurn PD; Alkayed NJ
Resuscitation; 2008 Jan; 76(1):89-94. PubMed ID: 17728042
[TBL] [Abstract][Full Text] [Related]
10. Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice.
Zhu Y; Blum M; Hoff U; Wesser T; Fechner M; Westphal C; Gürgen D; Catar RA; Philippe A; Wu K; Bubalo G; Rothe M; Weldon SM; Dragun D; Schunck WH
PLoS One; 2016; 11(1):e0145645. PubMed ID: 26727266
[TBL] [Abstract][Full Text] [Related]
11. Female-favorable attenuation of coronary myogenic constriction via reciprocal activations of epoxyeicosatrienoic acids and nitric oxide.
Froogh G; Qin J; Kandhi S; Le Y; Jiang H; Luo M; Sun D; Huang A
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1448-54. PubMed ID: 27016584
[TBL] [Abstract][Full Text] [Related]
12. Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels.
Iliff JJ; Wang R; Zeldin DC; Alkayed NJ
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1352-63. PubMed ID: 19304946
[TBL] [Abstract][Full Text] [Related]
13. Pinocembrin protects rats against cerebral ischemic damage through soluble epoxide hydrolase and epoxyeicosatrienoic acids.
Wang SB; Pang XB; Gao M; Fang LH; Du GH
Chin J Nat Med; 2013 May; 11(3):207-13. PubMed ID: 23725831
[TBL] [Abstract][Full Text] [Related]
14. Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure.
Sun D; Cuevas AJ; Gotlinger K; Hwang SH; Hammock BD; Schwartzman ML; Huang A
Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1146-53. PubMed ID: 24561863
[TBL] [Abstract][Full Text] [Related]
15. Protection of salvianolic acid A on rat brain from ischemic damage via soluble epoxide hydrolase inhibition.
Wang SB; Pang XB; Zhao Y; Wang YH; Zhang L; Yang XY; Fang LH; Du GH
J Asian Nat Prod Res; 2012; 14(11):1084-92. PubMed ID: 23106500
[TBL] [Abstract][Full Text] [Related]
16. Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response.
Keserü B; Barbosa-Sicard E; Popp R; Fisslthaler B; Dietrich A; Gudermann T; Hammock BD; Falck JR; Weissmann N; Busse R; Fleming I
FASEB J; 2008 Dec; 22(12):4306-15. PubMed ID: 18725458
[TBL] [Abstract][Full Text] [Related]
17. Soluble epoxide hydrolase disruption as therapeutic target for wound healing.
Sander AL; Sommer K; Neumayer T; Fleming I; Marzi I; Barker JH; Frank J; Jakob H
J Surg Res; 2013 Jun; 182(2):362-7. PubMed ID: 23122666
[TBL] [Abstract][Full Text] [Related]
18. Beyond detoxification: a role for mouse mEH in the hepatic metabolism of endogenous lipids.
Marowsky A; Meyer I; Erismann-Ebner K; Pellegrini G; Mule N; Arand M
Arch Toxicol; 2017 Nov; 91(11):3571-3585. PubMed ID: 28975360
[TBL] [Abstract][Full Text] [Related]
19. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.
Larsen BT; Miura H; Hatoum OA; Campbell WB; Hammock BD; Zeldin DC; Falck JR; Gutterman DD
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H491-9. PubMed ID: 16258029
[TBL] [Abstract][Full Text] [Related]
20. Generation and characterization of epoxide hydrolase 3 (EPHX3)-deficient mice.
Hoopes SL; Gruzdev A; Edin ML; Graves JP; Bradbury JA; Flake GP; Lih FB; DeGraff LM; Zeldin DC
PLoS One; 2017; 12(4):e0175348. PubMed ID: 28384353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
